Population
Patients with pulmonary hypertension associated with left heart disease (PH-LHD)
Design
Review
Authors
Loading...
PAH therapies lack support in PH-LHD; leaves open sildenafil role for prospective trials.
Management of pulmonary hypertension due to left heart disease should focus on optimizing heart failure therapy and corrective valve surgery, as PAH-specific therapies lack evidence in this setting.
Amir et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: